CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
OILS4CURE is focused on developing medicinal products from full spectrum cannabis extracts, specifically targeting refractory epilepsy linked to tuberous sclerosis complex in children. The project aims to advance the therapy YCJ-01 for this rare pediatric condition.
OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on full spectrum medicinal cannabis extracts.
It is developing a drug to manage refractory epilepsy associated with tuberous sclerosis complex (YCJ-01) and another for Leukodystrophies (YCJ-02), both paediatric rare diseases.
This project only deals with the development of our first and most advanced therapy directed at tuberous sclerosis complex (TSC).
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
